Abbott files SNDA for MAC prophylaxis.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D018791:CD4 Lymphocyte Count; D017291:Clarithromycin / Q000627:therapeutic use*; D004311:Double-Blind Method; D004352:Drug Resistance, Microbial; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D015337:Multicenter Studies as Topic; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000517:prevention & control*; D010919:Placebos; D016032:Randomized Controlled Trials as Topic
D010919:Placebos; D017291:Clarithromycin